✦ LIBER ✦

PCV20 A COST EFFECTIVENESS ANALYSIS OF SPIRONOLACTONE IN THE MANAGEMENT OF PATIENTS WITH SEVERE CHRONIC HEART FAILURE (CHF) IN THE IRISH HEALTHCARE SETTING

✍ Scribed by L Tilson; B McGowan; M Barry; M Ryan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Analysis of Ivabradin

✍ Borowiec, L.; Faluta, T.; Filipiak, K.J.; Niewada, M.; Wrona, W. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PCV43: PREDICTING THE BURDEN OF CONGESTI

✍ A Joglekar; C Chao; P Kadison 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PCV19: A COST-EFFECTIVENESS ANALYSIS OF

✍ I Squire; A Hebborn; A Ratcliffe; A McGuire 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

CV3 A COST-EFFECTIVENESS ANALYSIS OF CAN

✍ M Lamotte; L Annemans; B Schockaert 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Are β-blockers needed in patients receiv

✍ Henry Krum; Paul Mohacsi; Hugo A. Katus; Michael Tendera; Jean-Lucien Rouleau; M 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 279 KB

A cost-effectiveness analysis of enalapr

✍ Butler, J. R. G. ;Fletcher, P. J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB